Argent Biopharma Ltd (MGCLF)

[BostonErin]

I agree. New companies tend to trade on potential. I think at one point Aurora was trading at 500x revenue that was high (and a great time in my life lol). 500 is def high I also think 70x’s (where it is now is high)

I think one major thing that sets MGCLF apart is, they’ll have the revenue to justify market cap. Also, there revenue isn’t solely based off growing cannabis right out of the gate if cannabis ever becomes a commodity MGC I don’t think will be affected.

They are also self sufficient- the grow, produce their own cbd etc etc

End of 2017 a lot of the big Canadian LP’s started taking on more debt to offer more than just Cannabis.... MGC started with a broad range. Auscan having Canopy train the doctors (and they know what works because they did it) is HUGE for MGC as Cannepil is being released. They have 100 patients signed up at $1,000,000, they have an alliance with Epilepsy Action of Australia and they have Canopy growth training doctors on prescriptions of cannabis. I can’t imagine at least 5% of the 80,000 Australians suffering with refractory epilepsy wanting this medication then we have 2.6 million sufferers in Europe.... remember Cannepil is cheaper than other meds

End of year should be HUGE for MGCLF